Patent · US Active

CCR6 compounds

US9340509B2 · kind B2 · utility

4Cited by

3References

17Claims

0Family size

Assignee

CHEMOCENTRYX, INC. · US

Inventors

Daniel Dairaghi · Palo Alto, US
Dean R. Dragoli · Los Altos, US
Jarek Kalisiak · Mountain View, US
Christopher W. Lange · Hayward, US
Manmohan Reddy Leleti · Sunnyvale, US
Yandong Li · San Jose, US
Rebecca M. Lui · Mountain View, US
Venkat Reddy Mali · Cupertino, US
Viengkham Malathong · Mountain View, US
Jay P. Powers · Pacifica, US
Hiroko Tanaka · Foster City, US
Joanne Tan · San Francisco, US
Matthew J. Walters · Pacifica, US
Ju Yang · Palo Alto, US
Penglie Zhang · Foster City, US

Key dates

Filing date	Dec 2, 2014
Grant date	May 17, 2016
Priority date	—
Expiry date	Dec 2, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D405/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of formula (I) are provided which are useful in the treatment of diseases or conditions modulated at least in part by CCR6:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.